Sign in
4/A

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-26-002894

Chief Accounting Officer bought 15,000 shares at $1.89 ($28,350)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lerner Neil Chief Accounting Officer 2026-04-29 Purchase +15,000 $1.89 $28,350 397,500 D
Open-market purchases · 15,000 sh · avg $1.89 · $28,350
Loading xslF345X06/ownership.xml…